Social

AWE's Mega Event Lucky Draw - Round Two Delights

The Excitement Reaches New Heights HONG KONG,Feb. 14,2025-- Following the success of round one lucky draw,AsiaWorld-Expo (AWE) proudly announces the launch of the "AWE Mega Event Lucky Draw – Ro

Social

Feb 17, 2025

CIMB Singapore Maintains Leading Position On Returns For New Business Accounts Opening

New customers enjoy 3.0%*p.a. on SGD BusinessGo / BusinessGo-i Account and 3.8%* p.a. on USD Interest Plus Current Account / USD BusinessGo-i Account

Social

Feb 17, 2025

INFOMEDIA TO ACQUIRE 50% OF INTELLEGAM - AN ENTREPRENEURIAL AUTOMOTIVE AI STARTUP IN EUROPE

SYDNEY,Feb. 14,2025-- Infomedia Ltd (ASX: IFM) is pleased to announce that it has entered into a binding agreement to acquire 50% of European AI startup,Intellegam GmbH (Intellegam),for a purchase pri

Social

Feb 17, 2025

ATFX Attends ACBC NSW Chinese New Year Gala 2025, Strengthening Australia-China Business Ties

SYDNEY,Feb. 14,2025-- ATFX was honored to participate in the ACBC NSW Chinese New Year Gala 2025,a premier event that brings together business and government leaders to celebrate the strong economic r

Social

Feb 17, 2025

Get Ready! JETOUR T1 Will Usher in the Lite Off-Road Era

WUHU,China,Feb. 14,2025--The T1 series,a new member ofJETOUR brand with a lite off-road shape artfully blending sportiness and toughness,has been awarded the 2024 Red Dot Design Concept Award. By winn

Social

Feb 17, 2025

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Social

Feb 14, 2025

1 ... 74 75 76 77 78 79 80 ... 120